nach oben

Familial Cancer

Erschienen in:

03.08.2020 | Letter to the Editor

Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al.

verfasst von: Leah H. Biller, Sapna Syngal, Matthew B. Yurgelun

Erschienen in: Familial Cancer | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Excerpt

We thank the editors for the opportunity to respond to the correspondence by Møller et al. regarding our review “Recent Advances in Lynch Syndrome” [1] published in January 2019. …

Biller LH, Syngal S, Yurgelun MB (2019) Recent advances in Lynch syndrome. Fam Cancer 18(2):211–219CrossRef

Sanchez A, Navarro M, Ocaña T, Pineda M, Rodriguez-Moranta F, Soriano A et al (2017) Colorectal cancer incidence in Lynch syndrome patients: first report of a multicenter nation-wide study. Gastroenterology 152(5):S552CrossRef

Engel C, Vasen HF, Seppala T, Aretz S, Bigirwamungu-Bargeman M, de Boer SY, et al. (2018) No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies. Gastroenterology 155(5):1400-9e2CrossRef

Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D et al (2018) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut 67(7):1306–1316CrossRef

Dominguez-Valentin M, Seppala TT, Sampson JR, Macrae F, Winship I, Evans DG et al (2019) Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report. Hered Cancer Clin Pract 17:28CrossRef

National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Colorectal (Version 1.2020). https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf.

Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balmana J et al (2019) Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(10):1558–1571CrossRef

Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW et al (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33(2):209–217CrossRef

Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223–262 (quiz 63)CrossRef

10.

Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol 109(8):1159–1179CrossRef

Titel: Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al.
verfasst von: Leah H. Biller
Sapna Syngal
Matthew B. Yurgelun
Publikationsdatum: 03.08.2020
Verlag: Springer Netherlands
Erschienen in: Familial Cancer / Ausgabe 2/2021
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-020-00199-w

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al.

Excerpt

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer

Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas

Quantitative evaluation of MSI testing using NGS detects the imperceptible microsatellite changed caused by MSH6 deficiency

Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants

Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy

Recent advances in Lynch syndrome

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie